Terns Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
TERN
CUSIP
880881107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 880881107 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 6.8% 2/5/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (10)
Schonfeld Strategic Advisors LLC 13G/A 4.9% 5/15/2025
Event 3/31/2025
Orbimed Advisors LLC 13D/A
4.8% 11/5/2025
Event 11/3/2025
Citadel Advisors LLC 13G/A
4.1% 2/14/2025
Event 12/31/2024
Deep Track Capital, LP 13G/A
3.0% 2/13/2026
Event 12/31/2025
Vivo Opportunity Fund Holdings, L.P. 13G/A
2.5% 2/13/2026
Event 1/31/2025
Adage Capital Management, L.P. 13G/A
1.8% 5/13/2026
Event 3/31/2026
Commodore Capital LP 13G/A
1.4% 2/17/2026
Event 12/31/2025
Soleus Capital Master Fund, L.P. 13G/A
0.2% 2/12/2026
Event 12/31/2025
Morgan Stanley 13G/A 0% 6/5/2026
Event 5/31/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q2 2 12.5 k $660k
2026 Q1 328 125 M $6.56B
2025 Q4 250 123 M $4.95B
2025 Q3 143 88.6 M $666M
2025 Q2 131 83.1 M $310M
2025 Q1 141 83.1 M $230M
2024 Q4 158 86.1 M $477M
2024 Q3 158 79.5 M $663M
2024 Q2 127 65.6 M $447M
2024 Q1 113 63.2 M $415M
2023 Q4 104 63.6 M $413M
2023 Q3 95 61.7 M $310M
2023 Q2 105 57.7 M $505M
2023 Q1 80 53.2 M $630M
2022 Q4 66 49.7 M $506M
2022 Q3 46 30.3 M $178M
2022 Q2 43 14.7 M $36.6M
2022 Q1 45 16.8 M $50.0M
2021 Q4 38 16.5 M $117M
2021 Q3 35 16.7 M $174M
2021 Q2 37 16.6 M $204M
2021 Q1 43 17.9 M $394M